Autoantibody Status
Cross-source consensus on Autoantibody Status from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Comparisons
Other
Highlighted claims
- Rheumatoid arthritis is divided into autoantibody-positive and autoantibody-negative subtypes with different clinical and molecular profiles. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
- Autoantibody-positive rheumatoid arthritis has a worse prognosis and more destructive course than autoantibody-negative disease. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
- Autoantibody-positive patients respond better to rituximab than autoantibody-negative patients. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach
- Prior research found hydroxychloroquine comparable to methotrexate in autoantibody-negative rheumatoid arthritis, but not in autoantibody-positive disease. — PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA) trial: a multicentre, open-label, randomised controlled trial comparing routine care with a tailor-made approach